INS and Hyperglycemia: Since prilocaine is an inhibitory drug of action potential propagation, which is contrary to the supposed increased electrical signaling to induce greater insulin release in treating hyperglycemia, it may be repositioned to attain stimulatory effects in activating the action potential but without compromising its specificity to sodium ion channels.